Dow Up 0.76% Nasdaq Up 0.69%

Pharmacyclics Inc. (PCYC)

-NasdaqGS
123.68 Up 2.36(1.95%) Oct 24, 4:00PM EDT
Prev Close:121.32
Open:121.55
Bid:121.00 x 100
Ask:N/A
1y Target Est:157.56
Beta:1.09
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:120.53 - 124.19
52wk Range:82.51 - 154.89
Volume:715,590
Avg Vol (3m):899,221
Market Cap:9.31B
P/E (ttm):110.53
EPS (ttm):1.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PCYC

Comparison

Symbol% ChgMkt Cap
PCYCUp 1.95%9.31B
CTICUp 1.27%346.69M
MRKUp 1.73%166.18B

Key Statistics

Forward P/E (1 yr):12,368.00
P/S (ttm):20.99
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.38
Quarterly EPS Est (Sep-14) :0.38
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2,034.19

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Pharmacyclics, Inc., a biopharmaceutical company, designs, develops, and commercializes small-molecule drugs for the treatment of cancer and immune mediated diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback